Vaccines (Jul 2022)

Attitudes towards Vaccines, Intent to Vaccinate and the Relationship with COVID-19 Vaccination Rates in Individuals with Schizophrenia

  • Stéphane Raffard,
  • Sophie Bayard,
  • Margot Eisenblaetter,
  • Jérôme Attal,
  • Christelle Andrieu,
  • Isabelle Chereau,
  • Guillaume Fond,
  • Sylvain Leignier,
  • Jasmina Mallet,
  • Philippe Tattard,
  • Mathieu Urbach,
  • David Misdrahi,
  • Yasmine Laraki,
  • Delphine Capdevielle

DOI
https://doi.org/10.3390/vaccines10081228
Journal volume & issue
Vol. 10, no. 8
p. 1228

Abstract

Read online

Schizophrenia patients are at high risk of developing severe COVID-19 outcomes but recent evidence suggests that they are under-vaccinated. This study explored the role of potential attitudinal barriers by comparing schizophrenia patients with participants from the general population regarding COVID-19 vaccination rates, general attitudes towards vaccines, and willingness to take a COVID-19 vaccine. We conducted a cross-sectional study between April 2021 and October 2021. A total of 100 people with schizophrenia and 72 nonclinical controls were recruited. In our study, individuals with schizophrenia were under-vaccinated, despite similar general attitudes towards vaccination and higher willingness to be vaccinated against COVID-19 compared to nonclinical participants. In patients, negative attitudes toward vaccines were related to higher levels of negative psychotic symptoms and higher levels of paranoid ideation. As a whole, participants with more negative attitudes towards vaccines were less likely to be vaccinated against COVID-19 and had lower levels of trust in institutions. Vaccine hesitancy does not appear to be a major barrier for COVID-19 vaccine uptake amongst people with schizophrenia. This study suggests that disparities in COVID-19 vaccination rates in schizophrenia do not seem related to attitudinal but rather structural barriers.

Keywords